Unlock instant, AI-driven research and patent intelligence for your innovation.

Aromatic ethylene compound, and preparation method, intermediate, pharmaceutical composition and application thereof

A technology of aromatic ethylene and compounds, applied in the direction of drug combination, organic chemical method, acyclic/carbocyclic compound isotope introduction, etc., to achieve the best drug peak concentration, alleviate or treat cancer

Pending Publication Date: 2022-03-25
GUANGZHOU MAXINOVEL PHARMA CO LTD
View PDF7 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there have been no reports of biphenyl compounds successfully marketed as small molecule PD-1 / PD-L1 inhibitors in the prior art, and this situation needs to be resolved urgently

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aromatic ethylene compound, and preparation method, intermediate, pharmaceutical composition and application thereof
  • Aromatic ethylene compound, and preparation method, intermediate, pharmaceutical composition and application thereof
  • Aromatic ethylene compound, and preparation method, intermediate, pharmaceutical composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0246] (S,E)-1-(4-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-3-trifluoromethylbenzyl)piperidine -2-Formic acid (compound 1)

[0247]

[0248] Synthesis of compound 1-c

[0249] To a solution of 2-bromo-6-chlorobenzonitrile (2.16 g, 10.0 mmol) and phenylboronic acid (1.33 g, 11.0 mmol) in 1,4-dioxane (40 mL) was added water (4 mL), [1, 1'-Bis(diphenylphosphino)ferrocene]palladium dichloride (365 mg, 0.5 mmol) and sodium carbonate (2.65 g, 25.0 mmol). The reaction mixture was heated to 80°C and stirred under nitrogen for 16 hours. The reaction solution was cooled to room temperature, concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 6:1) to obtain compound 1-c (1.55 g, yield: 72%).

[0250] Synthesis of compound 1-b

[0251] Add water (8 mL), palladium acetate to compound 1-c (1.50 g, 7.0 mmol) and vinyl pinacol borate (2.13 g, 8.4 mmol) in 1,4-dioxane (80 mL) solution (78mg, 0.35mmol), 2-...

Embodiment 2

[0261] (S,E)-1-(3-chloro-4-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperidine-2- Formic acid (compound 2)

[0262]

[0263] Synthesis of compound 2-a

[0264] Compound 1-b (205.0mg, 1.0mmol) and 4-bromo-3-chlorobenzaldehyde (240.9mg, 1.1mmol) were dissolved in toluene solution (30mL), and N,N'-diisopropylethylamine was added (387 mg, 3.0 mmol) and bis(tri-tert-butylphosphine)palladium (51.1 mg, 0.1 mmol). The reaction solution was replaced with nitrogen three times at room temperature, heated to 90° C., and stirred for 10 hours. The reaction solution was cooled to room temperature, diluted with ethyl acetate (100 mL), washed with water (100 mL×3) and saturated brine (100 mL) successively, the obtained organic phase was dried over anhydrous sodium sulfate, concentrated under reduced pressure, and the residue was washed with Purification by silica gel column chromatography (petroleum ether: ethyl acetate = 20:1-5:1) gave compound 2-a (270 mg, yield: 78%).

[0265] S...

Embodiment 3

[0270](S,E)-1-(3-chloro-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperidine-2- Formic acid (compound 3)

[0271]

[0272] Synthesis of compound 3-c

[0273] Phenylboronic acid (1.626g, 13.34mmol) and 2,6-dibromotoluene (5.0g, 20.0mmol) were dissolved in a mixed solution of 1,4-dioxane (60mL) and water (3mL), and added to [ 1,1'-Bis(diphenylphosphino)ferrocene]palladium dichloride (1.154 g, 1.334 mmol) and sodium carbonate (3.535 g, 33.35 mmol). After the reaction system was replaced with nitrogen three times, it was heated to 80° C. and stirred for 16 hours. The reaction solution was cooled to room temperature, diluted with ethyl acetate (100 mL), washed with water (100 mL×3) and saturated brine (100 mL) successively, the obtained organic phase was dried over anhydrous sodium sulfate, concentrated under reduced pressure, and the residue was washed with Purify by silica gel column chromatography (petroleum ether) to obtain compound 3-c (1.9 g, yield: 57.2%).

[0...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an aromatic ethylene compound as well as a preparation method, an intermediate, a pharmaceutical composition and application thereof. The aromatic ethylene compound disclosed by the invention is shown as a formula I-0. The aromatic ethylene compound provided by the invention has an obvious inhibition effect on PD-1 / PD-L1, has higher drug peak concentration, larger area under a drug time curve and better oral bioavailability, is a very effective small-molecule inhibitor for PD-1 / PD-L1, and can effectively relieve or treat related diseases such as cancers and the like.

Description

technical field [0001] The invention relates to an aromatic vinyl compound, a preparation method, an intermediate, a pharmaceutical composition and applications thereof. Background technique [0002] PD-1 (programmed death 1) programmed death receptor 1 is an important immunosuppressive molecule. It is a member of the CD28 superfamily and was originally cloned from the apoptotic mouse T-cell hybridoma 2B4.11. Immunomodulation targeting PD-1 is of great significance in anti-tumor, anti-infection, anti-autoimmune diseases and organ transplant survival. Its ligand PD-L1 can also be used as a target, and the corresponding antibody can also play the same role. [0003] PD-1 / PD-L1 plays a negative immune regulatory role. When PD-1 on the cell surface is coupled to PD-L1, it can lead to Tyr phosphorylation of the immunoreceptor Tyrosine-based Swithmotifs (ITSM) domain in the cytoplasmic region of T cells, and then phosphorylate Dyed Tyr can recruit the phosphatases protein tyro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D211/60
CPCC07D211/60C07D265/30C07C255/58C07D241/04C07C217/58C07D401/12C07C22/08C07C229/22C07C47/55C07C47/575C07C255/56C07D213/61C07C317/18C07B59/001A61P35/00A61P35/02A61P31/04A61P31/12A61P19/02A61P37/02A61P9/10A61P9/00A61P19/08C07B2200/05
Inventor 王玉光吴添智蔡森林何敏吴新亮张顺利张农
Owner GUANGZHOU MAXINOVEL PHARMA CO LTD